Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for NDA 203568

KYNAMRO (MIPOMERSEN SODIUM)
200MG/ML (200MG/ML) Marketing Status: Discontinued

Active Ingredient: MIPOMERSEN SODIUM
Proprietary Name: KYNAMRO
Dosage Form; Route of Administration: SOLUTION; SUBCUTANEOUS
Strength: 200MG/ML (200MG/ML)
Reference Listed Drug: Yes
Reference Standard: No
TE Code: 
Application Number: N203568
Product Number: 001
Approval Date: Jan 29, 2013
Applicant Holder Full Name: KASTLE THERAPEUTICS LLC
Marketing Status:  Discontinued
Patent and Exclusivity Information

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English